Directors got plenty of skin in the game, so you would hope they would only sell out for what they consider a fair price. And they should know.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025